This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Review

Multiple myeloma/hypercalcemia

Babatunde O Oyajobi

Arthritis Research & Therapy 2007, 9(Suppl 1):S4 doi:10.1186/ar2168

Accesses  

  • Last 30 days: 111 accesses
  • Last 365 days: 1431 accesses
  • All time: 6838 accesses